Industry › BioTech
Press Releases
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
Avance Clinical
May 07, 2021 00:00 HKT/SGT
花旗：给予贝康医疗(2170.HK)「买入」评级，目标价40港元
Suzhou Basecare Medical Corporation Limited
May 05, 2021 11:00 HKT/SGT
花旗：給予貝康醫療(2170.HK)「買入」評級，目標價40港元
Suzhou Basecare Medical Corporation Limited
May 05, 2021 11:00 HKT/SGT
花旗医药首次覆盖贝康医疗(2170.HK): 买入/高风险评级，目标价40港币
Suzhou Basecare Medical Corporation Limited
May 04, 2021 16:00 HKT/SGT
花旗醫藥首次覆蓋貝康醫療(2170.HK): 買入/高風險評級，目標價40港幣
Suzhou Basecare Medical Corporation Limited
May 04, 2021 16:00 HKT/SGT
